NewAmsterdam Pharma Announces Closing of Upsized $479.0

Dec 13, 2024 · NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters’ Option to Purchase ...

CouponFollow Extension

$479
OFF

NewAmsterdam Pharma Announces Closing Of Upsized $479.0

3 weeks from now

globenewswire.com

$479
OFF

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 13, 2024 · NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the …

yahoo.com

$479
OFF

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 13, 2024 · NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; …

stockhouse.com

$479
OFF

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 13, 2024 · NewAmsterdam Pharma (NAMS) has successfully closed its upsized public offering, raising $479.0 million through the sale of securities. The offering included 14,667,347 …

stocktitan.net

$479
OFF

NewAmsterdam Pharma Announces Closing Of Upsized ... - The …

3 weeks from now

Dec 14, 2024 · NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the …

manilatimes.net

$479
OFF

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 13, 2024 · NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Com...

businessinsider.com

$479
OFF

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 12, 2024 · NewAmsterdam Pharma Announces Closing of $479.0 Million Upsized Public Offering, Expanding Resources for Cardiovascular Disease Innovations In a significant stride …

csimarket.com

$479
OFF

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 13, 2024 · NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin

einpresswire.com

$479
OFF

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 13, 2024 · Comprehensive suite of tools for trading and investing in biotech stocks. FDA Calendar, PDUFA Date Calendar, Biotech Company Screener and Database and much more

biopharmcatalyst.com

$416
OFF

NewAmsterdam Pharma Announces Pricing Of Upsized $416.5 …

3 weeks from now

NewAmsterdam Pharma Announces Pricing of Upsized $416.5 Million Public Offering of Ordinary Shares and Pre-Funded Warrants. PDF Version. NAARDEN, the Netherlands and MIAMI, …

newamsterdampharma.com

$479
OFF

NewAmsterdam Pharma Announces Closing Of Upsized $479.0

3 weeks from now

Dec 13, 2024 · NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the …

tradingview.com

$416
OFF

NewAmsterdam Pharma Announces Pricing Of Upsized $416.5 …

3 weeks from now

Dec 11, 2024 · NewAmsterdam Pharma Announces Pricing of Upsized $416.5 Million Public Offering of Ordinary Shares and Pre-Funded Warrants PRESS RELEASE GlobeNewswire …

businessinsider.com

$416
OFF

NewAmsterdam Pharma Announces Pricing Of Upsized $416.5 …

3 weeks from now

Dec 12, 2024 · NewAmsterdam Pharma (NAMS) has announced the pricing of its upsized public offering, consisting of 12,117,347 ordinary shares at $24.50 per share and pre-funded …

stocktitan.net

$479
OFF

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 13, 2024 · NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the …

sherbrookerecord.com

$416
OFF

NewAmsterdam Pharma Announces Pricing Of Upsized $416.5 …

3 weeks from now

Dec 12, 2024 · NewAmsterdam Pharma Announces Pricing of Upsized $416.5 Million Public Offering of Ordinary Shares and Pre-Funded Warrants NewAmsterdam Pharma N.V. Wed, …

yahoo.com

FAQs about NewAmsterdam Pharma Announces Closing of Upsized $479.0 Coupon?

What is newamsterdam Pharma?

NewAmsterdam Pharma (Nasdaq: NAMS) is a late-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well-tolerated. We seek to fill a significant unmet need for a safe, well-tolerated and convenient LDL-lowering therapy. ...

What does newamsterdam do?

NewAmsterdam (Nasdaq: NAMS) is a clinical-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved therapies have not been sufficiently successful or well tolerated. ...

Who acted as financial advisers to newamsterdam?

Cantor Fitzgerald & Co. and Van Lanschot Kempen N.V. acted as financial advisers to the Company. NewAmsterdam (Nasdaq: NAMS) is a clinical-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved therapies have not been sufficiently successful or well tolerated. ...